Ginkgo Bioworks Shares Gain As Q4 Sales, FY22 Guidance Surpass Street ExpectationsBenzinga • 03/29/22
Ginkgo Bioworks Holdings, Inc. (DNA) CEO Jason Kelly on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/29/22
CDC, Concentric by Ginkgo and XpresCheck® Publish Results of CDC COVID-19 Air Travel Biosecurity Program at International AirportsPRNewsWire • 03/23/22
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2021 Results Presentation and Date for Annual Meeting of ShareholdersPRNewsWire • 03/17/22
Ginkgo Bioworks Announces Participation in Jefferies Virtual Synthetic Biology WeekPRNewsWire • 03/15/22
Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platformPRNewsWire • 03/14/22
Phytolon and Ginkgo Bioworks Collaborate to Take Biological Production of Vibrant Food Colors to the Next LevelPRNewsWire • 02/28/22
Did You Acquire (DNA) Before May 11, 2021? Should Management be Held Accountable for Investors Losses?Newsfile Corp • 02/01/22